JP2005510521A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005510521A5 JP2005510521A5 JP2003543576A JP2003543576A JP2005510521A5 JP 2005510521 A5 JP2005510521 A5 JP 2005510521A5 JP 2003543576 A JP2003543576 A JP 2003543576A JP 2003543576 A JP2003543576 A JP 2003543576A JP 2005510521 A5 JP2005510521 A5 JP 2005510521A5
- Authority
- JP
- Japan
- Prior art keywords
- polymer
- sustained release
- release composition
- poly
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 30
- 238000013268 sustained release Methods 0.000 claims 26
- 239000012730 sustained-release form Substances 0.000 claims 26
- 229920002959 polymer blend Polymers 0.000 claims 15
- 229920000642 polymer Polymers 0.000 claims 11
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical group C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims 8
- 229920002988 biodegradable polymer Polymers 0.000 claims 6
- 239000004621 biodegradable polymer Substances 0.000 claims 6
- 230000002209 hydrophobic effect Effects 0.000 claims 6
- 238000010521 absorption reaction Methods 0.000 claims 5
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 5
- 239000002202 Polyethylene glycol Substances 0.000 claims 4
- 239000013543 active substance Substances 0.000 claims 4
- 229920001400 block copolymer Polymers 0.000 claims 4
- 229920001577 copolymer Polymers 0.000 claims 4
- 229920001477 hydrophilic polymer Polymers 0.000 claims 4
- 229920001983 poloxamer Polymers 0.000 claims 4
- 229960000502 poloxamer Drugs 0.000 claims 4
- 229920000747 poly(lactic acid) Polymers 0.000 claims 4
- -1 polybutylene terephthalate Polymers 0.000 claims 4
- 229920001707 polybutylene terephthalate Polymers 0.000 claims 4
- 229920001223 polyethylene glycol Polymers 0.000 claims 4
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 claims 2
- 229920002732 Polyanhydride Polymers 0.000 claims 2
- 229920000954 Polyglycolide Polymers 0.000 claims 2
- 229920001710 Polyorthoester Polymers 0.000 claims 2
- 229920001600 hydrophobic polymer Polymers 0.000 claims 2
- 229920001993 poloxamer 188 Polymers 0.000 claims 2
- 229940044519 poloxamer 188 Drugs 0.000 claims 2
- 229920001992 poloxamer 407 Polymers 0.000 claims 2
- 229940044476 poloxamer 407 Drugs 0.000 claims 2
- 229920000117 poly(dioxanone) Polymers 0.000 claims 2
- 229940065514 poly(lactide) Drugs 0.000 claims 2
- 239000002745 poly(ortho ester) Substances 0.000 claims 2
- 229920001610 polycaprolactone Polymers 0.000 claims 2
- 239000004632 polycaprolactone Substances 0.000 claims 2
- 229920000515 polycarbonate Polymers 0.000 claims 2
- 239000004417 polycarbonate Substances 0.000 claims 2
- 229920002721 polycyanoacrylate Polymers 0.000 claims 2
- 229920006149 polyester-amide block copolymer Polymers 0.000 claims 2
- 229920002635 polyurethane Polymers 0.000 claims 2
- 239000004814 polyurethane Substances 0.000 claims 2
- 239000011859 microparticle Substances 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33286801P | 2001-11-12 | 2001-11-12 | |
| PCT/US2002/036365 WO2003041689A1 (en) | 2001-11-12 | 2002-11-12 | Biocompatible polymer blends and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005510521A JP2005510521A (ja) | 2005-04-21 |
| JP2005510521A5 true JP2005510521A5 (enExample) | 2006-01-05 |
Family
ID=23300202
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003543576A Pending JP2005510521A (ja) | 2001-11-12 | 2002-11-12 | 生体適合性ポリマーブレンドおよびその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7282216B2 (enExample) |
| EP (1) | EP1443907A1 (enExample) |
| JP (1) | JP2005510521A (enExample) |
| AU (1) | AU2002343681B2 (enExample) |
| CA (1) | CA2466998A1 (enExample) |
| WO (1) | WO2003041689A1 (enExample) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002085337A1 (en) | 2001-04-20 | 2002-10-31 | The University Of British Columbia | Micellar drug delivery systems for hydrophobic drugs |
| US6726918B1 (en) | 2000-07-05 | 2004-04-27 | Oculex Pharmaceuticals, Inc. | Methods for treating inflammation-mediated conditions of the eye |
| ATE306951T1 (de) | 2000-11-29 | 2005-11-15 | Allergan Inc | Verhinderung von transplantatabstossung im auge |
| FR2822834B1 (fr) * | 2001-04-02 | 2005-02-25 | Flamel Tech Sa | Suspension colloidale de nanoparticules a base de copolymeres amphiphile pour la vectorisation de principes actifs et leur mode de preparation |
| FR2840614B1 (fr) * | 2002-06-07 | 2004-08-27 | Flamel Tech Sa | Polyaminoacides fonctionnalises par de l'alpha-tocopherol et leurs applications notamment therapeutiques |
| FR2843117B1 (fr) * | 2002-07-30 | 2004-10-15 | Flamel Tech Sa | Polyaminoacides fonctionnalises par au moins un groupement hydrophobe et leurs applications notamment therapeutiques |
| US20050048099A1 (en) | 2003-01-09 | 2005-03-03 | Allergan, Inc. | Ocular implant made by a double extrusion process |
| FR2860516B1 (fr) * | 2003-10-03 | 2006-01-13 | Flamel Tech Sa | Homopolyaminoacides telecheliques fonctionnalises par des groupements hydrophobes et leurs applications notamment therapeutiques |
| FR2862535B1 (fr) * | 2003-11-21 | 2007-11-23 | Flamel Tech Sa | Formulations pharmaceutiques pour la liberation prolongee d'interleukines et leurs applications therapeutiques |
| FR2862541B1 (fr) * | 2003-11-21 | 2007-04-20 | Flamel Tech Sa | Formulations pharmaceutiques pour la liberation prolongee d'interferons et leurs applications therapeutiques |
| FR2862536B1 (fr) * | 2003-11-21 | 2007-11-23 | Flamel Tech Sa | Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s), ainsi que leurs applications notamment therapeutiques |
| WO2005079856A1 (en) * | 2004-02-23 | 2005-09-01 | The University Of British Columbia | Drug delivery compositions comprising hydrophobic polymers and amphipathic molecules |
| US8778014B1 (en) * | 2004-03-31 | 2014-07-15 | Advanced Cardiovascular Systems, Inc. | Coatings for preventing balloon damage to polymer coated stents |
| US20060198868A1 (en) * | 2005-01-05 | 2006-09-07 | Dewitt David M | Biodegradable coating compositions comprising blends |
| US20060149363A1 (en) * | 2005-01-06 | 2006-07-06 | Scimed Life Systems, Inc. | Optimally expanded, collagen sealed ePTFE graft with improved tissue ingrowth |
| EP1679065A1 (en) * | 2005-01-07 | 2006-07-12 | OctoPlus Sciences B.V. | Controlled release compositions for interferon based on PEGT/PBT block copolymers |
| US8192731B2 (en) * | 2005-10-25 | 2012-06-05 | Loctite (R&D) Limited | Thickened cyanoacrylate compositions |
| WO2008157540A1 (en) * | 2007-06-20 | 2008-12-24 | Alkermes, Inc. | Quench liquids and washing systems for production of microparticles |
| CN101820887A (zh) | 2007-07-25 | 2010-09-01 | 拜奥雷克斯治疗公司 | 干扰素控释药品以及使用相同药品治疗hcv感染 |
| US9107815B2 (en) | 2008-02-22 | 2015-08-18 | Allergan, Inc. | Sustained release poloxamer containing pharmaceutical compositions |
| WO2010114770A1 (en) * | 2009-03-30 | 2010-10-07 | Cerulean Pharma Inc. | Polymer-agent conjugates, particles, compositions, and related methods of use |
| WO2010114768A1 (en) * | 2009-03-30 | 2010-10-07 | Cerulean Pharma Inc. | Polymer-epothilone conjugates, particles, compositions, and related methods of use |
| WO2010117668A1 (en) * | 2009-03-30 | 2010-10-14 | Cerulean Pharma Inc. | Polymer-agent conjugates, particles, compositions, and related methods of use |
| CA2758260A1 (en) * | 2009-04-08 | 2010-10-14 | Surmodics, Inc. | Controlled release devices and methods for delivery of nucleic acids |
| US8883208B2 (en) * | 2009-04-08 | 2014-11-11 | Surmodics, Inc. | Particles for delivery of nucleic acids and related devices and methods |
| JP2013525299A (ja) | 2010-04-16 | 2013-06-20 | アパテック リミテッド | 生体材料 |
| US9173978B2 (en) | 2010-09-22 | 2015-11-03 | Ethicon, Inc. | Bioabsorbable polymeric compositions, processing methods, and medical devices therefrom |
| US20130142878A1 (en) * | 2011-12-01 | 2013-06-06 | Flow Pharma, Inc. | Peptide particle formulation |
| US20130149351A1 (en) * | 2011-12-09 | 2013-06-13 | University Of Southern California | Polymer scaffolds and their use in the treatment of vision loss |
| ES2612530T3 (es) * | 2012-03-30 | 2017-05-17 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Composición de microesferas, método de preparación y aplicaciones de la misma |
| US20150044147A1 (en) * | 2013-02-18 | 2015-02-12 | King Abdullah International Medical Research Center | Composition for management of periodontal disease |
| EP2986323A4 (en) * | 2013-04-16 | 2016-10-19 | Univ Case Western Reserve | NEUTRALLY LOADED SYNTHETIC BLOOD PLATES TO REDUCE A COMPLEMENT REACTION |
| US9775929B2 (en) * | 2014-04-14 | 2017-10-03 | University Of Maryland College Park | Solution blow spun polymer fibers, polymer blends therefor and methods and use thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0092918B1 (en) | 1982-04-22 | 1988-10-19 | Imperial Chemical Industries Plc | Continuous release formulations |
| US5578323A (en) | 1992-06-15 | 1996-11-26 | Emisphere Technologies, Inc. | Proteinoid carriers and methods for preparation and use thereof |
| US5330768A (en) | 1991-07-05 | 1994-07-19 | Massachusetts Institute Of Technology | Controlled drug delivery using polymer/pluronic blends |
| TW333456B (en) | 1992-12-07 | 1998-06-11 | Takeda Pharm Ind Co Ltd | A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide. |
| GB9412273D0 (en) | 1994-06-18 | 1994-08-10 | Univ Nottingham | Administration means |
| AU5004196A (en) | 1995-03-10 | 1996-10-02 | Boehringer Mannheim Gmbh | Polypeptide-containing pharmaceutical forms of administration in the form of microparticles and method for the preparation thereof |
| US5709852A (en) | 1995-12-05 | 1998-01-20 | Basf Corporation | Ethylene oxide/propylene oxide/ethylene oxide (EO/PO/EO) triblock copolymer carrier blends |
| US5980948A (en) * | 1996-08-16 | 1999-11-09 | Osteotech, Inc. | Polyetherester copolymers as drug delivery matrices |
| US6117949A (en) | 1998-10-01 | 2000-09-12 | Macromed, Inc. | Biodegradable low molecular weight triblock poly (lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties |
| US6201072B1 (en) * | 1997-10-03 | 2001-03-13 | Macromed, Inc. | Biodegradable low molecular weight triblock poly(lactide-co- glycolide) polyethylene glycol copolymers having reverse thermal gelation properties |
| WO2001041735A2 (en) | 1999-12-07 | 2001-06-14 | Amgen Inc. | Thermosensitive biodegradable hydrogels based on low molecular weight pluronics |
| US6296842B1 (en) * | 2000-08-10 | 2001-10-02 | Alkermes Controlled Therapeutics, Inc. | Process for the preparation of polymer-based sustained release compositions |
-
2002
- 2002-11-12 CA CA002466998A patent/CA2466998A1/en not_active Abandoned
- 2002-11-12 AU AU2002343681A patent/AU2002343681B2/en not_active Ceased
- 2002-11-12 WO PCT/US2002/036365 patent/WO2003041689A1/en not_active Ceased
- 2002-11-12 US US10/293,974 patent/US7282216B2/en not_active Expired - Fee Related
- 2002-11-12 EP EP02780641A patent/EP1443907A1/en not_active Withdrawn
- 2002-11-12 JP JP2003543576A patent/JP2005510521A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005510521A5 (enExample) | ||
| JP4907359B2 (ja) | 生分解可能なマルチブロックコポリマー | |
| Munim et al. | Poly (lactic acid) based hydrogels: Formation, characteristics and biomedical applications | |
| JP2004502720A5 (enExample) | ||
| EP2316490A3 (en) | Methods and compositions for enhanced delivery of bioactive molecules | |
| CA2339482C (en) | Composite hydrogel drug delivery systems | |
| US8652525B2 (en) | NSAID delivery from polyarylates | |
| US5665428A (en) | Preparation of peptide containing biodegradable microspheres by melt process | |
| US7901705B2 (en) | Antimicrobial releasing polymers | |
| JP2006516252A5 (enExample) | ||
| AU2002343681B2 (en) | Biocompatible polymer blends and uses thereof | |
| Huh et al. | PLGA-PEG block copolymers for drug formulations | |
| JP2010514474A5 (enExample) | ||
| JP2003519194A5 (enExample) | ||
| JP2008272467A (ja) | コーティングされたフィラメント | |
| Das et al. | Colchicine encapsulation within poly (ethylene glycol)-coated poly (lactic acid)/poly (?-caprolactone) microspheres-controlled release studies | |
| Jelonek et al. | Polyesters and polyestercarbonates for controlled drug delivery Part I. Tailoring of the drug release | |
| WO2007130134A3 (en) | Controlled release microparticles | |
| Tsung et al. | Biodegradable polymers in drug delivery systems | |
| Kırımlıoğlu | History, introduction, and properties of PLGA as a drug delivery carrier | |
| JP5927061B2 (ja) | シート状止血材 | |
| Snežana et al. | Polymeric matrix systems for drug delivery | |
| CN1225014A (zh) | 减少或消除术后粘着形成的方法和组合物 | |
| US20060286138A1 (en) | Novel biodegradable aliphatic polyesters and pharmaceutical compositions and applications thereof | |
| JP2000072692A (ja) | 徐放性基剤及び徐放性被覆剤、及びその製造方法 |